Literature DB >> 30795963

Prevalence of oncogenic Human papillomavirus and genetic diversity in the L1 gene of HPV16 HPV 18 HPV31 and HPV33 found in women from Vojvodina Province Serbia.

Gordana Kovacevic1, Vesna Milosevic2, Petar Knezevic3, Aleksandra Knezevic4, Ivana Knezevic5, Jelena Radovanov6, Natasa Nikolic2, Aleksandra Patic2, Vladimir Petrovic2, Ivana Hrnjakovic Cvjetkovic2, Ljiljana Stanisic7.   

Abstract

The main purpose of this paper is to estimate the pre-vaccination prevalence of 12 hrHPV types among 564 women from Vojvodina province (Serbia). The corrected contingency coefficient (Ccorr) was used to estimate the importance of association of examined HPV types and cytological diagnosis. The highest association with the abnormal cytology was observed for HPV 16 (Ccorr = 0.493) in all age groups of participants. The effect of HPV 16 was especially clear within the group of women older than 35 years (Ccorr = 0.691), compared with women younger than 35 (Ccorr = 0.333). The molecular characterization at the level of L1 gene of HPV 16, 18, 31 and 33 variants was for the first time assessed in our region. Nearly all HPV 16 isolates cluster with variant lineage A (96.4%) the remaining isolates clustering with variant lineage D. All of HPV 18 and HPV 33 isolates are clustering within the lineage A while isolates of HPV 31 group with lineages A and C. This contributes to understanding of intrinsic geographical and biological differences of examined HPV types and could be useful for development of cervical cancer screening strategies in Vojvodina (Serbia) and diagnosis of HPV related cervical cancer in general.
Copyright © 2019 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genotyping; HPV lineage; Human papillomavirus

Mesh:

Year:  2019        PMID: 30795963     DOI: 10.1016/j.biologicals.2019.02.001

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  6 in total

1.  Prevalence Oncogenic Human Papillomavirus in Cervical Cancer Patients in Riau Province Indonesia.

Authors:  Maya Savira; Donel Suhaimi; Andani Eka Putra; Yusrawati Yusrawati; Nur Indrawati Lipoeto
Journal:  Rep Biochem Mol Biol       Date:  2022-01

2.  Detecting Human Papillomavirus Type 16 in Cervical Cancer Patients with Molecular Variation of Gene L1 in Riau Province Indonesia.

Authors:  Maya Savira; Donel S; Andani Eka Putra; Yusrawati Yusrawati; Nur Indrawati Lipoeto
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

3.  Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia.

Authors:  Nataša K Rančić; Milan B Golubović; Mirko V Ilić; Aleksanda S Ignjatović; Radomir M Živadinović; Saša N Đenić; Stefan D Momčilović; Biljana N Kocić; Zoran G Milošević; Suzana A Otašević
Journal:  Medicina (Kaunas)       Date:  2020-08-13       Impact factor: 2.430

4.  The prevalence of 30 HPV genotypes detected by EUROArray HPV in cervical samples among unvaccinated women from Vojvodina province, Serbia.

Authors:  Gordana Kovacevic; Vesna Milosevic; Natasa Nikolic; Aleksandra Patic; Nela Dopudj; Jelena Radovanov; Ivana Hrnjakovic Cvjetkovic; Vladimir Petrovic; Milena Petrovic
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.240

5.  Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer.

Authors:  Ishita Gupta; Monika Ulamec; Melita Peric-Balja; Snjezana Ramic; Ala-Eddin Al Moustafa; Semir Vranic; Halema F Al-Farsi
Journal:  Hum Vaccin Immunother       Date:  2021-10-08       Impact factor: 4.526

6.  Human Papillomavirus Detected in Oropharyngeal Cancers from Chilean Subjects.

Authors:  Carolina Oliva; Diego Carrillo-Beltrán; Paul Boettiger; Iván Gallegos; Francisco Aguayo
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.